The weekly litigation news digest is live. Subscribe now

IP Verse

Pharmaceutical Composition For Cancer Treatment - EP3616720

The patent EP3616720 was granted to Osaka University on Feb 17, 2021. The application was filed on Mar 28, 2018 under application number EP19202367A. The patent is currently recorded with a legal status of "Revoked".

EP3616720

OSAKA UNIVERSITY
Application Number
EP19202367A
Filing Date
Mar 28, 2018
Status
Revoked
Aug 15, 2025
Publication Date
Feb 17, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Antitumor antibody that inhibits immunosuppression mediated by Treg cells or the like. The antibody decreases the cell counts of the tumor-infiltrating Treg cells and the tumor-infiltrating macrophage cells and inhibits tumor growth.

Patent Family

Patent Family

Patent Oppositions (11)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
GEVERS & ORESNov 17, 2021GEVERS PATENTSADMISSIBLE
GLAXOSMITHKLINENov 17, 2021KIMADMISSIBLE
JAMES POOLENov 17, 2021CARPMAELS & RANSFORDADMISSIBLE
POHLMANNov 17, 2021POHLMANADMISSIBLE
SCHIWECK WEINZIERL KOCH PATENTANWALTE PARTNERSCHAFT MBBNov 17, 2021SCHIWECK WEINZIERL KOCH PATENTANWALTE PARTNERSCHAFT MBBADMISSIBLE
ABBVIENov 16, 2021WILDINGADMISSIBLE
J A KEMPNov 16, 2021J A KEMPADMISSIBLE
PARK GROVENov 16, 2021SNODINADMISSIBLE
STRAWMANNov 15, 2021D YOUNGADMISSIBLE
KONIG SZYNKA TILMANN VON RENESSEOct 14, 2021KONIG SZYNKA TILMANN VON RENESSE DUSSELDORFADMISSIBLE
KONIG SZYNKA TILMANN VON RENESSEOct 14, 2021KONIG SZYNKA TILMANN VON RENESSE PATENTANWALTE PARTNERSCHAFT MBB DUSSELDORFADMISSIBLE

Patent Citations (29) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO0231140
DESCRIPTIONWO2005035586
DESCRIPTIONWO9411523
OPPOSITIONCA3124332
OPPOSITIONEP1904050
OPPOSITIONEP2530091
OPPOSITIONEP3431105
OPPOSITIONEP3903817
OPPOSITIONJP2017065603
OPPOSITIONJP2017185935
OPPOSITIONUS10087259
OPPOSITIONUS10550191
OPPOSITIONUS2009214533
OPPOSITIONUS6531506
OPPOSITIONUS6693130
OPPOSITIONWO2007044756
OPPOSITIONWO2008073160
OPPOSITIONWO2013131010
OPPOSITIONWO2015063187
OPPOSITIONWO2015179236
OPPOSITIONWO2016092419
OPPOSITIONWO2017198631
OPPOSITIONWO2017205014
OPPOSITIONWO2018112032
OPPOSITIONWO2018181425
OPPOSITIONWO2019157098
OPPOSITIONWO2020138489
OPPOSITIONWO2021178749
SEARCHWO2018112032

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents